such that correctly matching complexes would be pulled
into the A site, while incorrectly matching complexes
would dissociate. The advantage of the F site is that it
would be more accessible to ternary complexes of
eEF1A·GTP·aminoacyl-tRNA, as both the A site and
the P site appear to be partially occluded at the interface
of the large and small ribosomal subunits. However, the
biochemical evidence supporting the existence of the F
site is weak compared to that for the E site.
Assuming that all four of the ribosomal sites exist and
that they are functional, they can be characterized by
positions of the tRNAs on either the large or small
ribosomal subunits. Thus, following initiation, the Met-
tRNA
i
may be described as being in the P/P position
(both the aminoacyl end and the anticodon end of
the tRNA correspond to the P site (Figure 2) I or III).
In the next step, the initial binding of the aminoacyl-
tRNA is to the F/A site where the anticodon is in the A
site, but the aminoacyl end is in the F site, and this end of
the aminoacyl-tRNA is still bound to eEF1A·GTP
(Figure 3, IV). With correct codon/anticodon recog-
nition, GTP is hydrolyzed and eEF1A·GDP is released
from the ribosome, concomitant with the movement of
the aminoacyl end of the tRNA into the A site (now in
the A/A configuration; Figure 2, I). At the same time, any
tRNA in the E site (as would be true for most elongation
steps) would be released from the ribosome. Subsequent
reactions would cyclically yield the other states of
the ribosome (P/P A/A, E/P P/A, and then E/E P/P).
The Other Elongation Factor, eEF3
A translation elongation factor unique to yeast and fungi
is eEF3. This protein, which contains two-nucleotide-
binding sites, appears to be required for the nucleotide-
dependent release of the nonacylated tRNA from the
ribosomal E site. As this protein is an essential gene
product in yeast, it is surprising that an equivalent
activity has not been identified in other eukaryotes.
However, it has been noted in vitro that only elongation
reactions using yeast ribosomes demonstrate the eEF3
requirement, and thus this requirement for eEF3 would
appear to reflect unusual properties of the yeast
ribosome compared to other eukaryotic ribosomes.
Regulation of the Elongation Cycle
The major regulation of gene expression at the transla-
tional level occurs through the covalent modification of
translation initiation factors or regulatory proteins that
bind to the initiation factors. However, there is ample
evidence that regulation of translation also occurs at the
level of elongation although the degree of regulation (the
fold change in the elongation rate) is not as great as seen
with regulation of initiation. While eEF1A, eEF1B, and
eEF2 are all phosphorylated under different conditions,
eEF1A and eEF2 also contain unique posttranslational
modifications. eEF1A contains methylated lysines
(mono-, di-, or trimethyl lysine) and glycerylphosphor-
ylethanolamine. eEF2 contains a hypermodified
histidine residue (histidine #714 in mammalian eEF2’s)
that is found in all eukaryotic eEF2’s called diphtha-
mide. The diphthamide residue is a known inactivation
site for ADP-ribosylation catalyzed by either Diphtheria
or Pseudomonas A toxins with NAD serving as the
donor of the ADP group. There is tentative evidence that
this modification may be part of the normal cellular
regulation of eEF2 activity as well.
The best-studied regulation of any of the elongation
factors is via phosphorylation. In general, phosphoryl-
ation of eEF1A and eEF1B correlates well with increases
in the rate of elongation noted in vivo with either insulin
or phorbol ester treatment. Additionally, most phos-
phorylations of translation factors are associated with
an increased rate of protein synthesis. In contrast, the
phosphorylation of eEF2 leads to its inactivation. Under
most circumstances, changes in the elongation rate due
to changes in covalent modifications of eEF1A, eEF1B,
or eEF2 are associated with a coordinate change in the
rate of initiation of protein biosynthesis.
SEE ALSO THE FOLLOWING ARTICLES
EF-G and EF-Tu Structures and Translation Elongation
in Bacteria † Ribosome Structure † Translation
Elongation in Bacteria † Translation Initiation in
Bacteria: Factors and Mechanisms † Translation
Initiation in Eukaryotes: Factors and Mechanisms †
Translation Termination and Ribosome Recycling
GLOSSARY
E, A, P, and F sites Physical locations on the surface of the ribosome
that are occupied by aminoacyl- or peptidyl-tRNA.
elongation (of protein synthesis) The sequential steps that lead to the
addition of one amino acid at a time to the growing polypeptide
chain.
elongation factor (EF) A nonribosomal protein that facilitates the
process of elongation only. (Note: eukaryotic elongation factors are
designated eEF, where the lower case “e” signifies “eukaryotic.”)
initiation (of protein synthesis) The required steps that lead to the
placement of the initiator tRNA in the P site of the ribosome,
correctly base paired with the initiating AUG codon.
protein synthesis The process of joining amino acids in a specific
sequence through the a carbonyl and a amino groups via a peptide
bond that is templated by an mRNA molecule.
termination (of protein synthesis) The codon-directed (UAA, UAG or
UGA) process of cleavage (and therefore release) of the polypeptide
chain from the tRNA in the P site of the ribosome.
228 TRANSLATION ELONGATION IN EUKARYOTES